Evidence map›Paper›PMID 25574178›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2014

Safety and Tolerability of Essential Oil from Cinnamomum zeylanicum Blume Leaves with Action on Oral Candidosis and Its Effect on the Physical Properties of the Acrylic Resin.

Julyana de Araújo Oliveira, Ingrid Carla Guedes da Silva, Leonardo Antunes Trindade, Edeltrudes Oliveira Lima, Hugo Lemes Carlo, Alessandro Leite Cavalcanti, Ricardo Dias de Castro

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Effects of Cinnamon (Molecules (Basel, Switzerland) · 2020
    Review
  10. Article
  11. Red propolis hydroalcoholic extract inhibits the formation ofJournal of clinical and experimental dentistry · 2020
    Article
  12. Review
  13. Article
  14. Essential oils, their therapeutic properties, and implication in dentistry: A review.Journal of International Society of Preventive & Community Dentistry
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julyana de Araújo OliveiraPost-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil.
Ingrid Carla Guedes da SilvaPost-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil.
Leonardo Antunes TrindadePost-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil.
Edeltrudes Oliveira LimaPost-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil.
Hugo Lemes CarloPost-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil.
Alessandro Leite CavalcantiPost-Graduate Program in Dentistry, State University of Paraíba, Campina Grande, PB, Brazil.
Ricardo Dias de CastroPost-Graduate Program in Dentistry, Federal University of Paraíba, Campus I, João Pessoa, PB, Brazil ; Post-Graduate Program in Dentistry, State University of Paraíba, Campina Grande, PB, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anti-Candida activity of essential oil from Cinnamomum zeylanicum Blume, as well as its effect on the roughness and hardness of the acrylic resin used in dental prostheses, was assessed. The safety and tolerability of the test product were assessed through a phase I clinical trial involving users of removable dentures. Minimum inhibitory concentration (MIC) and minimum fungicidal concentrations (MFC) were determined against twelve Candida strains. Acrylic resin specimens were exposed to artificial saliva (GI), C. zeylanicum (GII), and nystatin (GIII) for 15 days. Data were submitted to ANOVA and Tukey posttest (α = 5%). For the phase I clinical trial, 15 healthy patients used solution of C. zeylanicum at MIC (15 days, 3 times a day) and were submitted to clinical and mycological examinations. C. zeylanicum showed anti-Candida activity, with MIC = 625.0 µg/mL being equivalent to MFC. Nystatin caused greater increase in roughness and decreased the hardness of the material (P < 0.0001), with no significant differences between GI and GII. As regards the clinical trial, no adverse clinical signs were observed after intervention. The substance tested had a satisfactory level of safety and tolerability, supporting new advances involving the clinical use of essential oil from C. zeylanicum.

Identifiers

PMID25574178
PMCPMC4276295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.